GeneDx Holdings (WGS) Non Operating Income: 2020-2025
Historic Non Operating Income for GeneDx Holdings (WGS) over the last 6 years, with Sep 2025 value amounting to -$4.1 million.
- GeneDx Holdings' Non Operating Income fell 461.63% to -$4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.5 million, marking a year-over-year increase of 69.98%. This contributed to the annual value of -$29.4 million for FY2024, which is 853.68% down from last year.
- Per GeneDx Holdings' latest filing, its Non Operating Income stood at -$4.1 million for Q3 2025, which was down 358.08% from $1.6 million recorded in Q2 2025.
- In the past 5 years, GeneDx Holdings' Non Operating Income ranged from a high of $121.0 million in Q3 2021 and a low of -$18.8 million during Q2 2024.
- In the last 3 years, GeneDx Holdings' Non Operating Income had a median value of -$1.1 million in 2023 and averaged -$2.4 million.
- As far as peak fluctuations go, GeneDx Holdings' Non Operating Income spiked by 20,265.83% in 2021, and later plummeted by 526.99% in 2024.
- Quarterly analysis of 5 years shows GeneDx Holdings' Non Operating Income stood at $75.6 million in 2021, then plummeted by 78.56% to $16.2 million in 2022, then slumped by 103.34% to -$541,000 in 2023, then slumped by 526.99% to -$3.4 million in 2024, then tumbled by 461.63% to -$4.1 million in 2025.
- Its last three reported values are -$4.1 million in Q3 2025, $1.6 million for Q2 2025, and -$1.5 million during Q1 2025.